JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 42:652-658, doi:10.1016/S0735-1097(03)00783-6
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huikuri, H. V.
Right arrow Articles by Myerburg, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huikuri, H. V.
Right arrow Articles by Myerburg, R. J.

CLINICAL RESEARCH: ACUTE MYOCARDIAL INFARCTION

Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era

Heikki V. Huikuri, MD, FACC*,*, Jari M. Tapanainen, MD*, Kai Lindgren, MD*, Pekka Raatikainen, MD*, Timo H. Mäkikallio, MD*, K. E. Juhani Airaksinen, MD* and Robert J. Myerburg, MD, FACC{dagger}

* Division of Cardiology, Department of Medicine, University of Oulu, Oulu, Finland
{dagger} Division of Cardiology, University of Miami, Miami, Florida, USA

Manuscript received December 20, 2002; revised manuscript received February 14, 2003, accepted March 20, 2003.

* Reprint requests and correspondence: Dr. Heikki V. Huikuri, Professor of Medicine. Division of Cardiology, Department of Internal Medicine, University of Oulu, P.O. Box 5000, FIN-90014, Oulu, Finland.
heikki.huikuri{at}oulu.fi

OBJECTIVES: This study assessed the predictive power of arrhythmia risk markers after an acute myocardial infarction (AMI).

BACKGROUND: Several risk variables have been suggested to predict the occurrence of sudden cardiac death (SCD), but the utility of these variables has not been well established among patients using medical therapy according to contemporary guidelines.

METHODS: A consecutive series of 700 patients with AMI was studied. The end points were total mortality, SCD, and nonsudden cardiac death (non-SCD). Nonsustained ventricular tachycardia (nsVT), ejection fraction (EF), heart rate variability, baroreflex sensitivity, signal-averaged electrocardiogram (SAECG), QT dispersion, and QRS duration were analyzed (n = 675). Beta-blocking therapy was used by 97% of the patients at discharge and by 95% at one and two years after AMI.

RESULTS: During a mean (±SD) follow-up of 43 ± 15 months, 37 non-SCDs (5.5%) and 22 SCDs (3.2%) occurred. All arrhythmia risk variables differed between the survivors and those with non-SCD (e.g., the standard deviation of N-N intervals was 98 ± 32 vs. 74 ± 21 ms [p < 0.001] and the QRS duration was 103 ± 22 vs.89 ± 16 ms [p < 0.001]). Sudden cardiac death was weakly predicted only by reduced EF (<0.40; p < 0.05), nsVT (p < 0.05), and abnormal SAECG (p < 0.05), but not by autonomic markers or standard ECG variables. The positive predictive accuracy of EF, nsVT, and abnormal SAECG as predictors of SCD was relatively low (8%, 12%, and 13%, respectively).

CONCLUSIONS: The common arrhythmia risk variables, particularly the autonomic and standard ECG markers, have limited predictive power in identifying patients at risk of SCD after AMI in the beta-blocking era.

Abbreviations and Acronyms
  AMI = acute myocardial infarction
  BRS = baroreflex sensitivity
  ECG = electrocardiogram
  EF = ejection fraction
  HRV = heat rate variability
  ICD = implantable cardioverter-defibrillator
  nsVT = nonsustained ventricular tachycardia
  NYHA = New York Heart Association
  SAECG = signal-averaged electrocardiogram
  SCD = sudden cardiac death




This article has been cited by other articles:


Home page
EuropaceHome page
L. Ding, W. Hua, H. Niu, K. Chen, and S. Zhang
Primary prevention of sudden cardiac death using implantable cardioverter defibrillators
Europace, September 1, 2008; 10(9): 1034 - 1041.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al.
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
J. Am. Coll. Cardiol., August 25, 2008; (2008) j.jacc.2008.05.003v1.
[Full Text] [PDF]


Home page
EuropaceHome page
H. S. Lim, G. Y.H. Lip, and H.-F. Tse
Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule
Europace, May 1, 2008; 10(5): 536 - 539.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. M. Gibson, Y. B. Pride, J. L. Buros, E. Lord, A. Shui, S. A. Murphy, D. S. Pinto, P. J. Zimetbaum, M. S. Sabatine, C. P. Cannon, et al.
Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
J. Am. Coll. Cardiol., February 5, 2008; 51(5): 546 - 551.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. V. Exner, K. M. Kavanagh, M. P. Slawnych, L. B. Mitchell, D. Ramadan, S. G. Aggarwal, C. Noullett, A. Van Schaik, R. T. Mitchell, M. A. Shibata, et al.
Noninvasive Risk Assessment Early After a Myocardial Infarction: The REFINE Study
J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2275 - 2284.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. J. Bunch, S. H. Hohnloser, and B. J. Gersh
Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors: Insights From the Randomized Trials of Implantable Cardioverter-Defibrillators
Circulation, May 8, 2007; 115(18): 2451 - 2457.
[Full Text] [PDF]


Home page
Med Decis MakingHome page
J. J. Bailey, M. Hodges, and T. R. Church
Decision to Implant a Cardioverter Defibrillator after Myocardial Infarction: The Role of Ejection Fraction v. Other Risk Factor Markers
Med Decis Making, March 1, 2007; 27(2): 151 - 160.
[Abstract] [PDF]


Home page
Eur Heart JHome page
D. E. Hofsten, K. Wachtell, B. Lund, H. Molgaard, K. Egstrup, and on behalf of the DANAMI-2 Investigators
Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty
Eur. Heart J., February 2, 2007; 28(4): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. D. Solomon, S. Zelenkofske, J. J.V. McMurray, P. V. Finn, E. Velazquez, G. Ertl, A. Harsanyi, J. L. Rouleau, A. Maggioni, L. Kober, et al.
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
N. Engl. J. Med., June 23, 2005; 352(25): 2581 - 2588.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. E. Buxton
Sudden Death after Myocardial Infarction -- Who Needs Prophylaxis, and When?
N. Engl. J. Med., June 23, 2005; 352(25): 2638 - 2640.
[Full Text] [PDF]


Home page
CirculationHome page
A. E. Buxton, A. J. Moss, A. E. Buxton, and A. J. Moss
Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator?
Circulation, May 17, 2005; 111(19): 2537 - 2549.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. Bauer, P. Guzik, P. Barthel, R. Schneider, K. Ulm, M. A. Watanabe, and G. Schmidt
Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era
Eur. Heart J., April 2, 2005; 26(8): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. H. Makikallio, P. Barthel, R. Schneider, A. Bauer, J. M. Tapanainen, M. P. Tulppo, G. Schmidt, and H. V. Huikuri
Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era
Eur. Heart J., April 2, 2005; 26(8): 762 - 769.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. L. Lee and C.-P. Lau
The use of signal-averaged electrocardiogram in risk stratification after acute myocardial infarction in the modern era
Eur. Heart J., April 2, 2005; 26(8): 747 - 748.
[Full Text] [PDF]


Home page
CirculationHome page
N. H.M. Kupper, G. Willemsen, M. van den Berg, D. de Boer, D. Posthuma, D. I. Boomsma, and E. J.C. de Geus
Heritability of Ambulatory Heart Rate Variability
Circulation, November 2, 2004; 110(18): 2792 - 2796.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. M. Kiviniemi, A. J. Hautala, T. Seppanen, T. H. Makikallio, H. V. Huikuri, and M. P. Tulppo
Saturation of high-frequency oscillations of R-R intervals in healthy subjects and patients after acute myocardial infarction during ambulatory conditions
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1921 - H1927.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. C. Haigney, W. Zareba, P. J. Gentlesk, R. E. Goldstein, M. Illovsky, S. McNitt, M. L. Andrews, A. J. Moss, and the MADIT II Investigators
QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients
J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1481 - 1487.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
K. Thygesen and B. F Uretsky
Acute ischaemia as a trigger of sudden cardiac death
Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D88 - D90.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. G Katritsis and A.J. Camm
Nonsustained ventricular tachycardia: where do we stand?
Eur. Heart J., July 1, 2004; 25(13): 1093 - 1099.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. M. Tapanainen, K. S. Lindgren, T. H. Makikallio, O. Vuolteenaho, J. Leppaluoto, and H. V. Huikuri
Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 757 - 763.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.